Nektar Therapeutics Reports Third Quarter 2025 Financial Results
Go back to Nektar Therapeutics Reports Third Quarter 2025 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 73.38 -1.15 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.53 | 52 Week High | $19.98 | |||
| Open | $75.10 | 52 Week Low | $10.52 | |||
| Day High | $76.23 | P/E | N/A | |||
| Day Low | $72.83 | EPS | $-1.45 | |||
| Volume | 417,591 | |||||

